https://m2.mtmt.hu/ eng 2026-10-23 17:47 JournalArticle 36093240 ADMIN_APPROVED true Amsterdam Neuroscience, Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Amsterdam Institute of Molecules, Medicines and Systems, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Roche Pharma Research and Early Development, Roche Innovation Center Basel, Neuroscience and Rare Diseases, Biomarkers, F. Hoffmann-La Roche Ltd., Basel, Switzerland Isotope Chemistry, Early Chemical Development, Pharmaceutical Sciences R&D, AstraZeneca, Gothenburg, Sweden “Momentum”, Laboratory of Neuroimmunology, HUN-REN Institute of Experimental Medicine, Budapest, Hungary Roche Pharma Research and Early Development, Roche Innovation Center Basel, Therapeutic Modalities, Small Molecule Research, Medicinal Chemistry, F. Hoffmann-La Roche Ltd., Basel, Switzerland Export Date: 15 August 2025; Cited By: 3; Correspondence Address: E.J.L. Stéen; Amsterdam Institute of Molecules, Medicines and Systems, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; email: j.steen@amsterdamumc.nl; CODEN: BCPCA 0 false 2026-10-22T06:11:23.753+0000 2026-05-20T09:01:53.691+0000 2025-04-15T12:17:04.988+0000 true 10069606 Pintér Ibolya Katalin /api/admin/10069606 Admin Ibolya Katalin Pintér (SE_AOK_TranszlációsMedInt_Admin5_PI, admin) true 2026-10-13T10:04:04.688+0000 2026-10-13T10:04:04.688+0000 2026-05-15T13:30:05.791+0000 true 10097128 Sass Dávid /api/admin/10097128 Admin Dávid Sass (SZTE admin5) true Admin 10025544 /api/admin/10025544 Katalin Lévayné Deseő (MTMT Központi admin) Lévayné Deseő Katalin true 10025544 true 2026-05-20T07:50:12.413+0000 true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Stéen, E. Johanna L. true true /api/journal/686 REVIEWED BIOCHEMICAL PHARMACOLOGY 0006-2952 1873-2968 true false 686 false 686 true 0006-2952 1873-2968 Journal FOREIGN 237 116900 116900 17 2025 Funding 2052015 /api/funding/2052015 Michael J. Fox Foundation for Parkinson’s Research(MJFF-022453) false true Funding 2052021 /api/funding/2052021 Marie Sklodowska-Curie Individual Fellowship(892572) false true Funding 2052022 /api/funding/2052022 European Union’s Horizon(2020) false true true 2025 true true true false true false GOLD 2026-10-22 true https://doi.org/10.1016/j.bcp.2025.116900 6 0 6 4 1 6 6 6 6 6 6 4 4 4 2 0 6 4 6 4 0 1 1 Folyóiratcikk Journal Article 24 6 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 5 3 5 3 2026 0 1 1 1 1 D1 false false false false 2025-07-14T12:17:10.054+0000 Neuroimmunológiai Kutatócsoport (HRN KOKI) 2 15 1 16 0 true 10025544 Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 126183390 /api/authorship/126183390 Stéen, E. Johanna L. 1 0.0625 true false false Stéen E. Johanna L. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183391 /api/authorship/126183391 Tousiaki, Efthalia-Natalia 2 0.0625 false false false Tousiaki Efthalia-Natalia true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183392 /api/authorship/126183392 Kingston, Lee 3 0.0625 false false false Kingston Lee true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183393 /api/authorship/126183393 van der Wildt, Berend 4 0.0625 false false false van der Wildt Berend true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183394 /api/authorship/126183394 Lénárt, Nikolett [Lénárt, Nikolett (neurobiológia), author] Laboratory of Neuroimmunology 5 0.063 false false false Author 10030597 /api/author/10030597 Nikolett Lénárt (neurobiológia) Lénárt Nikolett true 10030597 true Lénárt Nikolett true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183395 /api/authorship/126183395 Beaino, Wissam 6 0.0625 false false false Beaino Wissam true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183396 /api/authorship/126183396 Verlaan, Mariska 7 0.0625 false false false Verlaan Mariska true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183397 /api/authorship/126183397 Zarzycka, Barbara 8 0.0625 false false false Zarzycka Barbara true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183398 /api/authorship/126183398 Zinnhardt, Bastian 9 0.0625 false false false Zinnhardt Bastian true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183399 /api/authorship/126183399 Dénes, Ádám [Dénes, Ádám (Neurobiológia, ne...), author] Laboratory of Neuroimmunology 10 0.063 false false false Author 10012934 /api/author/10012934 Ádám Dénes (Neurobiológia, neuroimmunológia) Dénes Ádám true 10012934 true Dénes Ádám true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183400 /api/authorship/126183400 Gobbi, Luca 11 0.0625 false false false Gobbi Luca true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183401 /api/authorship/126183401 de Esch, Iwan J.P. 12 0.0625 false false false de Esch Iwan J.P. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183402 /api/authorship/126183402 Elmore, Charles S. 13 0.0625 false false false Elmore Charles S. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183403 /api/authorship/126183403 Windhorst, Albert D. 14 0.0625 false false false Windhorst Albert D. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183404 /api/authorship/126183404 Honer, Michael 15 0.0625 false false false Honer Michael true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 126183405 /api/authorship/126183405 Leurs, Rob 16 0.0625 false true false Leurs Rob true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 29243581 /api/publicationidentifier/29243581 DOI: 10.1016/j.bcp.2025.116900 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1016/j.bcp.2025.116900 https://doi.org/10.1016/j.bcp.2025.116900 false true PublicationIdentifier 29245652 /api/publicationidentifier/29245652 REAL: 217894 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GOLD true 217894 https://real.mtak.hu/217894 false true PublicationIdentifier 29374448 /api/publicationidentifier/29374448 WoS: 001465901500001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001465901500001 https://www.webofscience.com/wos/woscc/full-record/001465901500001 false true PublicationIdentifier 29374474 /api/publicationidentifier/29374474 Scopus: 105001946898 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105001946898 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105001946898 false true PublicationIdentifier 29374449 /api/publicationidentifier/29374449 PubMed: 40179990 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 40179990 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40179990&dopt=Abstract false true PublicationIdentifier 29243582 /api/publicationidentifier/29243582 Other URL: https://linkinghub.elsevier.com/retrieve/pii/S0006295225001625 PlainSource 40 /api/publicationsource/40 Other URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true GOLD true IDENTICAL https://linkinghub.elsevier.com/retrieve/pii/S0006295225001625 https://linkinghub.elsevier.com/retrieve/pii/S0006295225001625 false true SjrRating 11611982 /api/sjrrating/11611982 sjr:D1 (2025) Scopus - Pharmacology BIOCHEMICAL PHARMACOLOGY 0006-2952 1873-2968 32 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 3004 /api/classificationexternal/3004 Scopus - Pharmacology true 3004 true D1 DIRECT true true Reference 65374018 /api/reference/65374018 1. Abbracchio 2006: International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy., Pharmacol. Rev., 58, p. 281, DOI: 10.1124/pr.58.3.3 1 10.1124/pr.58.3.3 false true Reference 65374019 /api/reference/65374019 2. Jacobson 2010: P2Y nucleotide receptors: promise of therapeutic applications., Drug Discov. Today, 15, p. 570, DOI: 10.1016/j.drudis.2010.05.011 2 10.1016/j.drudis.2010.05.011 false true Reference 65374020 /api/reference/65374020 3. von Kügelgen 2020: Molecular pharmacology of P2Y receptor subtypes., Biochem. Pharmacol., 187 3 false true Reference 65374021 /api/reference/65374021 4. Von Kügelgen 2016: Pharmacology and structure of P2Y receptors., Neuropharmacology, 104, p. 50, DOI: 10.1016/j.neuropharm.2015.10.030 4 10.1016/j.neuropharm.2015.10.030 false true Reference 65374022 /api/reference/65374022 5. Zhang 2014: Structure of the human P2Y12 receptor in complex with an antithrombotic drug., Nature, 508, p. 115, DOI: 10.1038/nature13083 5 10.1038/nature13083 false true Reference 65374023 /api/reference/65374023 6. Zhang 2014: Agonist-bound structure of the human P2Y12 receptor., Nature, 508, p. 119, DOI: 10.1038/nature13288 6 10.1038/nature13288 false true Reference 65374024 /api/reference/65374024 7. Paoletta 2015: Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information., J. Comput. Aided. Mol. Des., 29, p. 737, DOI: 10.1007/s10822-015-9858-z 7 10.1007/s10822-015-9858-z false true Reference 65374025 /api/reference/65374025 8. Pons 2022: Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation., Biochem. Pharmacol., 206, DOI: 10.1016/j.bcp.2022.115291 8 10.1016/j.bcp.2022.115291 false true Reference 65374026 /api/reference/65374026 9. Li 2022: Structural insights into signal transduction of the purinergic receptors P2Y1R and P2Y12R., Protein Cell, 14, p. 382 9 false true Reference 65374027 /api/reference/65374027 10. Sasaki 2003: Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain., Glia, 44, p. 242, DOI: 10.1002/glia.10293 10 10.1002/glia.10293 false true Reference 65374028 /api/reference/65374028 11. Haynes 2006: The P2Y12 receptor regulates microglial activation by extracellular nucleotides., Nat. Neurosci., 9, p. 1512, DOI: 10.1038/nn1805 11 10.1038/nn1805 false true Reference 65374029 /api/reference/65374029 12. Mansour 2020: P2Y12 inhibition beyond thrombosis: effects on inflammation., Int. J. Mol. Sci., 21, p. 1 12 false true Reference 65374030 /api/reference/65374030 13. Butovsky 2014: Identification of a unique TGF-β-dependent molecular and functional signature in Microglia., Nat. Neurosci., 17, p. 131, DOI: 10.1038/nn.3599 13 10.1038/nn.3599 false true Reference 65374031 /api/reference/65374031 14. Colonna 2017: Microglia function in the central nervous system during health and neurodegeneration., Annu. Rev. Immunol., 35, p. 441, DOI: 10.1146/annurev-immunol-051116-052358 14 10.1146/annurev-immunol-051116-052358 false true Reference 65374032 /api/reference/65374032 15. Beaino 2017: Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis., J. Neuroinflammation., 14, p. 259, DOI: 10.1186/s12974-017-1034-z 15 10.1186/s12974-017-1034-z false true Reference 65374033 /api/reference/65374033 16. Janssen 2018: PET imaging of microglial activation - beyond targeting TSPO., Molecules, 23, p. 1, DOI: 10.3390/molecules23030607 16 10.3390/molecules23030607 false true Reference 65374034 /api/reference/65374034 17. Ma 2022: Strategies for targeting the P2Y12 receptor in the central nervous system., Bioorg. Med. Chem. Lett., 71, DOI: 10.1016/j.bmcl.2022.128837 17 10.1016/j.bmcl.2022.128837 false true Reference 65374035 /api/reference/65374035 18. I. Kirk. New Assay. Patent application WO 00/33080, June 8 2000. 18 false true Reference 65374036 /api/reference/65374036 19. van Giezen 2009: Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation., J. Thromb. Haemost., 7, p. 1556, DOI: 10.1111/j.1538-7836.2009.03527.x 19 10.1111/j.1538-7836.2009.03527.x false true Reference 65374037 /api/reference/65374037 20. Macfarlane 1983: 2-methylthioadenosine[β-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets., J. Clin. Invest., 71, p. 420, DOI: 10.1172/JCI110786 20 10.1172/JCI110786 false true Reference 65374038 /api/reference/65374038 21. El-Tayeb 2005: Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors., Bioorganic Med. Chem. Lett., 15, p. 5450, DOI: 10.1016/j.bmcl.2005.08.104 21 10.1016/j.bmcl.2005.08.104 false true Reference 65374039 /api/reference/65374039 22. Bach 2011: A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor., Bioorganic Med. Chem. Lett., 21, p. 2877, DOI: 10.1016/j.bmcl.2011.03.088 22 10.1016/j.bmcl.2011.03.088 false true Reference 65374040 /api/reference/65374040 23. Bach 2013: Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor., Eur. J. Med. Chem., 65, p. 360, DOI: 10.1016/j.ejmech.2013.04.007 23 10.1016/j.ejmech.2013.04.007 false true Reference 65374041 /api/reference/65374041 24. Villa 2018: Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state., Theranostics, 8, p. 5400, DOI: 10.7150/thno.25572 24 10.7150/thno.25572 false true Reference 65374042 /api/reference/65374042 25. van der Wildt 2021: Novel thienopyrimidine-based PET tracers for P2Y 12 receptor imaging in the brain., ACS Chem. Neurosci., 12, p. 4465, DOI: 10.1021/acschemneuro.1c00641 25 10.1021/acschemneuro.1c00641 false true Reference 65374043 /api/reference/65374043 26. Gruber 2007: An algorithm for the deconvolution of mass spectrosopic patterns in isotope labeling studies. evaluation for the hydrogen-deuterium exchange reaction in ketones., J. Org. Chem., 72, p. 5778, DOI: 10.1021/jo070831o 26 10.1021/jo070831o false true Reference 65374044 /api/reference/65374044 27. Wilkinson 2017: Pharmacological evaluation of novel bioisosteres of an adamantanyl benzamide P2X 7 receptor antagonist., ACS Chem. Neurosci., 8, p. 2374, DOI: 10.1021/acschemneuro.7b00272 27 10.1021/acschemneuro.7b00272 false true Reference 65374045 /api/reference/65374045 28. Császár 2022: Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions., J. Exp. Med., 219, DOI: 10.1084/jem.20211071 28 10.1084/jem.20211071 false true Reference 65374046 /api/reference/65374046 29. Bach 2013: Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate Drug AZD1283., J. Med. Chem., 56, p. 7015, DOI: 10.1021/jm400820m 29 10.1021/jm400820m false true Reference 65374047 /api/reference/65374047 30. Zech 2012: Identification of high-affinity P2Y 12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone., J. Med. Chem., 55, p. 8615, DOI: 10.1021/jm300771j 30 10.1021/jm300771j false true Reference 65374048 /api/reference/65374048 31. Baqi 2009: High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y 12 receptors., J. Med. Chem., 52, p. 3784, DOI: 10.1021/jm9003297 31 10.1021/jm9003297 false true Reference 65374049 /api/reference/65374049 32. Springthorpe 2007: From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis., Bioorganic Med. Chem. Lett., p. 6013, DOI: 10.1016/j.bmcl.2007.07.057 32 10.1016/j.bmcl.2007.07.057 false true Reference 65374050 /api/reference/65374050 33. Kim 2005: Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor., Biochem. Pharmacol., 70, p. 266, DOI: 10.1016/j.bcp.2005.04.021 33 10.1016/j.bcp.2005.04.021 false true Reference 65374051 /api/reference/65374051 34. Barrett 2013: A selective high-affinity antagonist of the P2Y 14 receptor inhibits UDP-glucose–stimulated chemotaxis of human neutrophils., Mol. Pharmacol., 84, p. 41, DOI: 10.1124/mol.113.085654 34 10.1124/mol.113.085654 false true Reference 65374052 /api/reference/65374052 35. Bendels 2019: Safety screening in early drug discovery: an optimized assay panel., J. Pharmacol. Toxicol. Methods, 99 35 false true Reference 65374053 /api/reference/65374053 36. Janssen 2018: Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation., Sci. Rep., 8, p. 1, DOI: 10.1038/s41598-018-24814-0 36 10.1038/s41598-018-24814-0 false true Reference 65374054 /api/reference/65374054 37. Hoffmann 2014: Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12-receptor., J. Thromb. Haemost., 12, p. 1898, DOI: 10.1111/jth.12719 37 10.1111/jth.12719 false true Reference 65374055 /api/reference/65374055 38. Mamedova 2004: Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors., Biochem. Pharmacol., 67, p. 1763, DOI: 10.1016/j.bcp.2004.01.011 38 10.1016/j.bcp.2004.01.011 false true Reference 65374056 /api/reference/65374056 39. Amino acid homology was determined by pairwise sequence alignment in ICM-Pro (Version 3.9-1c, Molsoft L.L.C., La Jolla, USA) using the Zero End-gap Global Alignment (ZEGA) algorithm (reference 40) with default settings. UniProt codes: Q9H244 (hP2Y12R), Q9EPX4 (rP2Y12R) and Q9CPV9 (mP2Y12R). 39 false true Reference 65374057 /api/reference/65374057 40. Abagyan 1997: Do aligned sequences share the same fold?., J. Mol. Biol., 273, p. 355, DOI: 10.1006/jmbi.1997.1287 40 10.1006/jmbi.1997.1287 false true Reference 65374058 /api/reference/65374058 41. Yang 2021: G protein-coupled receptors: structure- and function-based drug discovery., Signal Transduct. Target. Ther., 6 41 false true /api/publication/36093240 Stéen E. Johanna et al. Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor. (2025) BIOCHEMICAL PHARMACOLOGY 0006-2952 1873-2968 237<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Stéen E. Johanna L. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Tousiaki Efthalia-Natalia </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kingston Lee </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >van der Wildt Berend </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10030597"><a href="/gui2/?type=authors&mode=browse&sel=10030597" target="_blank">Lénárt Nikolett (<span class="authorship-author-name">Lénárt Nikolett</span> <span class="authorAux-mtmt"> neurobiológia</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Neuroimmunology</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Beaino Wissam </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Verlaan Mariska </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Zarzycka Barbara </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Zinnhardt Bastian </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10012934"><a href="/gui2/?type=authors&mode=browse&sel=10012934" target="_blank">Dénes Ádám (<span class="authorship-author-name">Dénes Ádám</span> <span class="authorAux-mtmt"> Neurobiológia, neuroimmunológia</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Institute of Experimental Medicine">HUN-REN IEM</span>/Laboratory of Neuroimmunology</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Gobbi Luca </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >de Esch Iwan J.P. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Elmore Charles S. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Windhorst Albert D. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Honer Michael </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Leurs Rob </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36093240" target="_blank">Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor</a></div> <div> <span class="journal-title">BIOCHEMICAL PHARMACOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0006-2952">0006-2952</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1873-2968">1873-2968</a>)</span>: <span class="journal-volume">237</span> <span class="page"> Paper 116900. 17 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1016/j.bcp.2025.116900" target="_blank" href="https://doi.org/10.1016/j.bcp.2025.116900"> DOI </a> </span> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:black" title="217894" target="_blank" href="https://real.mtak.hu/217894"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001465901500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001465901500001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105001946898" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105001946898"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="40179990" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40179990&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="https://linkinghub.elsevier.com/retrieve/pii/S0006295225001625" target="_blank" href="https://linkinghub.elsevier.com/retrieve/pii/S0006295225001625"> Other URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Biochemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 6</span> | Independent citation: 4 | Self citation: 2 | Unknown citation: 0 | Number of citations in WoS: 6 | Number of citations in Scopus:&nbsp;6 | WoS/Scopus assigned:&nbsp;6 | Number of citations with DOI:&nbsp;6 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36093240&sort=publishedYear,desc&sort=title"> Number of cited publications: 1 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 36093240</span> | <span class="status-data status-ADMIN_APPROVED"> Admin approved </span> Core Citing | <span class="type-subtype">Journal Article ( Article ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Michael J. Fox Foundation for Parkinson’s Research(MJFF-022453), Marie Sklodowska-Curie Individual Fellowship(892572), European Union’s Horizon(2020) </div> <div class="lastModified">Last Modified: 2026.05.20. 11:01 Katalin Lévayné Deseő (MTMT Központi admin) </div> <div class="lockedBy">Centrally managed 2026.05.20. 09:50 Katalin Lévayné Deseő (MTMT Központi admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Amsterdam Neuroscience, Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Amsterdam Institute of Molecules, Medicines and Systems, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Roche Pharma Research and Early Development, Roche Innovation Center...</pre> </div></div>